Clinical Trial Update: Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 study evaluating AMG 706 in subjects with advanced gastrointestinal stromal tumors (GIST). It provides the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• AMG 706 (motesanib)

Snippet

Sponsor: Amgen | Conditions: Gastrointestinal Cancer | Phase 2 | Status: COMPLETED